Myriad Genetics
Offers genetic diagnostic tests to guide personalized medical care.
Company facts
- Founded
- 1991
- Employees
- 2,700
- Headquarters
- United States
- CEO
- Paul J. Diaz
- Type
- Public
- Listed
- NASDAQ: MYGN
- Subsidiaries
- Assurex Health, Counsyl, Gateway Genomics, Crescendo Bioscience, Myriad International
About
Myriad Genetics, Inc. is a leading molecular diagnostic company dedicated to saving lives and improving patient health through transformative medicine. We focus on providing high-value genetic insights that empower patients and healthcare providers to make better-informed decisions, ultimately personalizing healthcare to each individual. With a strong commitment to innovation, Myriad has developed a portfolio of tests that identify the risk of developing certain diseases, enabling proactive health management. Our advanced testing capabilities cover hereditary cancers and other complex medical conditions, making us a trusted partner in the healthcare community.